Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella
Researchers aim to discover dominant subtypes of plasmablasts initiating from the MMR vaccine in order to develop neutralizing antibody candidate therapies
Article content
SEATTLE — The Vanderbilt University Medical Center and Parse Biosciences today announced a strategic collaboration to generate a single cell atlas focused on understanding the diversity of plasmablasts – early immune cell clonotypes critical in the formation of neutralizing antibodies – for measles, mumps and rubella. This effort aims to build the most comprehensive understanding of the formation of neutralizing antibodies to the vaccine and to identify the dominant and effective antibodies to these infectious agents.
Article content
Dr. James Crowe, Director of Vanderbilt's Center for Antibody Therapeutics, will lead the development of the large-scale immune cell study.
Article content
'This collaboration enables us to create the largest single cell atlas of neutralizing plasmablasts ever assembled,' states Crowe. 'By sequencing and mapping tens of millions of B cell receptors, we can uncover the most potent antibody lineages, accelerating antibody discovery and informing vaccine design. These insights give us a critical edge in responding to both emerging infectious threats and optimizing existing immunization strategies.'
Article content
Leveraging Parse's Evercode chemistry, the GigaLab can rapidly produce large single cell datasets, sequencing these immune cells with exceptional granularity at scale.
Article content
'We are thrilled to be working with Dr. James Crowe and the Vanderbilt team on such an exciting project,' says Dr. Charlie Roco, Chief Technology Officer at Parse Biosciences. 'The speed and scale achieved with the GigaLab will enable us to sequence unprecedented numbers of immune cells present after exposure to these viral antigens. In addition to better understanding the immune diversity, clonal expansion, and antigen specificity of antibodies across a number of diverse patients, these findings may also identify novel therapeutic antibodies.'
Article content
About Parse Biosciences
Article content
Parse Biosciences is a global life sciences company whose mission is to accelerate progress in human health and scientific research. Empowering researchers to perform single cell sequencing with unprecedented scale and ease, its pioneering approach has enabled groundbreaking discoveries in cancer treatment, tissue repair, stem cell therapy, kidney and liver disease, brain development, and the immune system.
Article content
With technology developed at the University of Washington by co-founders Alex Rosenberg and Charles Roco, Parse has raised over $100 million in capital and is used by 3,000 customers across the world. Its growing portfolio of products includes Evercode™ Whole Transcriptome, Evercode™ TCR, Evercode™ BCR, Gene Select, and a solution for data analysis, Trailmaker™.
Article content
Article content
Article content
Article content
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
2 Ultra-High-Yield Dividend Stocks at 10-Year Lows to Buy in July
Key Points The packaged food industry is facing its largest downturn in over a decade. Consumers are seeking alternatives amid growing health concerns and lifestyle changes. Conagra Brands and Campbell's have become too cheap to ignore. 10 stocks we like better than Conagra Brands › Packaged food giants Conagra Brands (NYSE: CAG) and The Campbell's Company (NASDAQ: CPB) are both down more than 25% year to date and are hovering around their lowest levels in over a decade. Both companies are industry giants. Conagra owns brands like Orville Redenbacher's, Slim Jim, Boom Chicka Pop, Hunt's, Reddi-Wip, Marie Callender's, and more. In addition to its flagship soup line, Campbell's also owns a variety of pasta sauce and dip brands, as well as snacks like Pepperidge Farm, Kettle, Cape Cod, Snyder's of Hanover, Lance, Goldfish, and more. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Conagra and Campbell's stocks are so beaten down that they yield 6.8% and 5.1%, respectively. Here's why the sell-off in both high-yield dividend stocks is a buying opportunity for patient investors. A severe slowdown The packaged food industry has faced numerous challenges in recent years. Most recently, pullbacks in consumer spending and inflation have pressured consumer goods companies -- but the downturn is particularly bad for packaged food names. Packaged food companies are facing macroeconomic headwinds and changes in consumer behavior. A shift away from processed and packaged foods toward healthier options presents a significant challenge for the industry. Especially from companies that sell frozen and processed meals rather than just snacks and beverages. The Trump administration established the Make America Healthy Again Commission to address U.S. health concerns. In April, the U.S. Department of Health and Human Services and U.S. Food and Drug Administration announced measures to phase out all petroleum-based synthetic dyes and replace them with natural ingredients. On June 25, Conagra announced that it would remove Food, Drug & Cosmetic (FD&C) colors from its U.S. frozen product portfolio by the end of 2025. The company also stated that it will not offer products with FD&C colors sold to K-12 schools beginning with the 2026 through 2027 school year and will discontinue the manufacturing of products with FD&C colors in its U.S. retail portfolio by 2027. Conagra's peers, like General Mills, Kraft Heinz, and others, made similar announcements in June. The regulatory pressure throws a wrench in an already challenging operating environment for the industry, but it could be a net positive in the long run. Acquisition remorse In addition to macro challenges and paradigm shifts in the industry, some packaged food companies have also been dealing with the aftermath of bad acquisitions. In 2018, Conagra bought Pinnacle Foods for $10.9 billion -- a disastrous move in hindsight, given the market cap of Conagra at the time of this writing is just $9.7 billion. That same year, Campbell's bought Snyder's-Lance for $6.1 billion -- making the company a major player in the snack category through chips, pretzels, popcorn, nuts, and cookies. Campbell's then bought Sovos Brands for $2.7 billion in March 2024 to diversify its product lineup through pasta sauces, dry pasta, frozen entrees, frozen pizza, yogurt, and more soup varieties. The acquisition isn't terrible, as it opens the door to more premium brands. But it did add debt to Campbell's balance sheet. Having to manage a larger interest expense makes it even harder for the company to navigate industrywide challenges. Combined, those two acquisitions cost Campbell's $8.8 billion, nearly as much as its market cap at the time of this writing of $9.2 billion. Like Conagra, Campbell's overpaid for these brands in hindsight. Conagra's and Campbell's revenues have steadily climbed over the past few years, but that's mainly due to acquisitions -- not organic growth. Meanwhile, operating margins have significantly fallen due to weakening demand. CAG Revenue (TTM) data by YCharts In response to the poor results, both stocks are now at their lowest levels in over a decade, which has boosted their dividend yields to their highest levels in that period. CAG Dividend Yield data by YCharts Two high-yield stocks at attractive valuations As bad as Conagra's and Campbell's results have been, both companies remain impeccable cash cows. Conagra's free cash flow (FCF) per share is $3.02 compared to its $1.40 dividend per share, while Campbell's has $2.41 in FCF per share compared to a dividend per share of $1.52. So although both companies are experiencing weakening balance sheets, at least they can still support their dividends with cash from the business. In terms of valuations, both stocks are dirt cheap -- with Campbell's sporting a 12.8 price-to-FCF and 10.5 forward price-to-earnings (P/E) ratio compared to just a 6.8 price-to-FCF ratio for Conagra and an 8.3 forward P/E. For context, Campbell's 10-year median price-to-FCF ratio is 15.8 and Conagra's is 16.3 -- illustrating just how severely discounted these stocks are compared to their historical averages. Conagra and Campbell's have fallen far enough Conagra and Campbell's have been hit with a four-pronged punch of self-inflicted poor decision-making, shifts in consumer behavior, macro challenges, and regulatory changes. However, both stocks are dirt cheap and generate plenty of cash to support their high dividends. Conagra reports earnings on July 10, which will give investors a better idea of where the company is headed and the impact of changes to its food ingredients and additives. At their lowest levels in over a decade, now is a good time for income investors to scoop up shares of Conagra and Campbell's despite both stocks being heavily out of favor. Should you invest $1,000 in Conagra Brands right now? Before you buy stock in Conagra Brands, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Conagra Brands wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $695,481!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $969,935!* Now, it's worth noting Stock Advisor 's total average return is1,053% — a market-crushing outperformance compared to179%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 7, 2025 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool recommends Campbell's and Kraft Heinz. The Motley Fool has a disclosure policy.
CTV News
2 hours ago
- CTV News
Study: health of U.S. children deteriorating
Winnipeg Watch A new study looking at the overall health of U.S. Children leads MedicalWatch for July 8, 2025.
Globe and Mail
4 hours ago
- Globe and Mail
Nanotechnology Market to Reach USD 197.43 Billion by 2030 Driven by Healthcare and Electronics Applications
"Nanotechnology Market" Mordor Intelligence has published a new report on the Nanotechnology Market offering a comprehensive analysis of trends, growth drivers, and future projections. Introduction According to a 2025 report on the Nanotechnology market by Mordor Intelligence, the market is projected to grow from USD 104.88 Billion in 2025 to 197.43 billion in 2030 The Nanotechnology market has been witnessing steady growth due to increasing research investments, expanding industrial applications, and the demand for advanced materials with superior mechanical, chemical, and electrical properties Key Trends in the Nanotechnology Market Expansion in Healthcare Applications Nanotechnology is increasingly used in the healthcare sector, particularly in drug delivery, diagnostics, and imaging. Nanoparticles enable targeted delivery of drugs to specific cells or tissues, improving treatment outcomes and minimizing side effects. Research is also progressing in using nanomaterials for cancer therapy, regenerative medicine, and nanosensors for early disease detection. Growing Role in Electronics and Semiconductor s The demand for smaller, faster, and more efficient electronic devices has led to the adoption of nanotechnology in semiconductor manufacturing. Nanoscale materials are used to produce transistors, memory chips, and display technologies with enhanced performance and reduced power consumption, supporting innovations in consumer electronics and communication devices. Rising Government and Private Investments Global governments and private institutions are increasing investments in nanotechnology research and development. Programs such as the National Nanotechnology Initiative (NNI) in the US and Horizon Europe in the EU support research that advances applications in energy storage, materials science, and environmental remediation, boosting market growth. Environmental Applications Gaining Momentum Nanotechnology is being utilized for environmental solutions, including water purification, air filtration, and pollution control. Nanomaterials like nano catalysts and Nano adsorbents are effective in removing contaminants, reflecting the market's growing focus on sustainability and clean technologies. Market Segmentation By Type of Offering The market is divided into several key categories based on the nature of the technology: Nanomaterials: Materials engineered at the nanoscale, including nanoparticles, nanotubes, carbon-based substances, metal oxides, polymeric nanomaterials, nano Clays, and nanocellulose. Nanocomposites: Engineered materials combining nano-sized fillers within structural, functional, or smart composites to enhance properties. By Manufacturing Process Top-Down: Techniques like photolithography, etching, high-energy ball milling starting with bulk materials and scaling down to nanoscale. By Material Category Products are classified according to their chemical nature: Carbon-based nanomaterials: Includes carbon nanotubes (CNTs), graphene, and fullerenes. Metal and metal oxide nanoparticles: Such as gold, silver, titanium dioxide, zinc oxide. Dendrimers, quantum dots: Including II‑VI, III‑V semiconductors, and other nano-crystalline structures By Application Diverse industrial and consumer uses include: Medical & Healthcare: Drug delivery systems, imaging contrast agents, implants. Electronics & Computing: Components in logic ICs, displays, memory. Energy Storage & Production: Nanotech in lithium‑ion batteries, fuel cells, and solar photovoltaics. Major Players Nanotechnology Industry Leaders Imina Technologies SA Swiss-based specialist in micro- and nanoprobing robotic systems for SEM, FIB, and dual-beam microscopes. Their miBot™ platform delivers sub-nanometer positioning for electrical characterization, failure analysis, and manipulation of semiconductor devices. Widely used by top semiconductor companies and research institutes Applied Nanotech, Inc. Develops nanotech solutions focusing on electronics and thermal management. Known for printed electronics, advanced coatings, and nanoscale sensor integration advancing semiconductor and electronics applications. Bruker Nano GmbH Provides high-precision analytical instrumentation including atomic force microscopy, X-ray, and electron microscopy systems for research and industry applications in materials science, life sciences, and semiconductor development. DuPont de Nemours, Inc. A major chemical company with deep investments in nanotechnology R&D. Their portfolio includes silver nanowire conductive inks, nanofiber products (e.g., Nomex® Nano for firefighter protection), and organic-inorganic nanocomposite materials. They recently acquired C3Nano's silver nanowire technology to enhance their flexible transparent conductor offerings Conclusion The nanotechnology market is poised for substantial growth in the coming years, driven by expanding applications across healthcare, electronics, energy, and environmental sectors. The integration of nanomaterials in drug delivery systems, diagnostics, semiconductors, and energy storage solutions enhances product performance and enables targeted, efficient solutions for complex challenges. Industry Related Reports Nanomaterials market: The Nanomaterials Market is segmented by product type, including nanoparticles, nanofibers, nanotubes, and others; by structure type, covering non-polymer organic nanomaterials and polymeric nanomaterials; by material category, such as carbon-based and metal-based nanomaterials; by end-user industry, including construction, electronics, energy, and more; and by geography, encompassing Asia-Pacific, North America, Europe, South America, and the Middle East and Africa. Nanosensors Market: The Nanosensors Market is segmented by type, including biological nanosensors, chemical nanosensors, and physical nanosensors; by end-use verticals, covering aerospace and defense, automotive and industrial, consumer electronics, healthcare, power generation, and other sectors; and by geography, spanning North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. For More information: North America Nano Sensors Market: The North America Nano Sensors Market is segmented by type, which includes optical sensors, electrochemical sensors, and electromechanical sensors; by end-user, covering consumer electronics, power generation, automotive, aerospace and defense, healthcare, and industrial sectors; and by country. Market sizes and forecasts are presented in terms of value (USD) for each of these segments. About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics. For any inquiries or to access the full report, please contact:media@
